Phibro Animal Health Corporation (PAHC) Stock Analysis
Phibro is a discounted animal-health consolidator with valuable Zoetis assets and durable feed-additive niches, but Brazil regulation, debt leverage, governance concerns, and weak technical momentum keep the opportunity firmly in transition.
Overview
Phibro Animal Health is a global production-animal health company spanning Animal Health, Mineral Nutrition, and Performance Products, with Animal Health driving most revenue and profit through medicated feed additives, vaccines, and nutritional specialties. Its products serve 4,200 customers in 100+ countries and are embedded in livestock productivity, food safety, and veterinary workflows. The Zoetis MFA acquisition materially expanded scale, but the investment case now hinges on integrating those assets, managing leverage, and navigating antimicrobial regulation—especially Brazil’s transition from growth-promotion use to prescription therapeutic labels.